 Leap Therapeutics, Inc. Nasdaq: LPTX, a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that, due to public health and safety concerns related to the outbreak of the novel coronavirus COVID-19, and to support the health and well-being of its stockholders, employees and others, the Company is changing its 2020 Annual Meeting of Stockholders the Annual Meeting to a virtual-only format. The virtual Annual Meeting is expected to provide stockholders with the same rights and opportunities to participate as they would have had at an in-person meeting. Stockholders can submit questions related to the matters to be voted on at the virtual Annual Meeting by using the instructions on the virtual meeting website listed below. 